… In some patients surgical debulking of the tumor has been claimed to facilitate medical
treatments and be beneficial, as well as other antitumour treatments, which are considered in …

Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that
originate from endocrine glands such as the pituitary, the parathyroids, and the (neuroendocrine) …

… appropriate medical treatment the hormonal activity, primary tumor localization, tumor grading
… role of the different medical treatment options in the treatment algorithms for NEN patients. …

… treatment of gastroenteropancreatic neuroendocrine tumors (GEPNETs). Octreotide (O) and
lanreotide, SST analogs, have shown in vitro and in vivo antisecretory and antiproliferative …

… This review focuses on the medical treatment of metastatic panNENs, excluding surgical, …
for well-differentiated G1 or G2 pancreatic neuroendocrine tumors (panNETs) and for G3 …

… Furthermore, NETs arise from secretory cells of the neuroendocrine system that can result
in … of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States …

… In its 2000 classification of digestive tumors, the World Health Organization (WHO) used
the term neuroendocrine tumor to describe a heterogeneous system of tumor made up of both …

… The main aims of the treatment are the control of the tumor growth and the control of the
secretory pattern of the neuroendocrine tumor cells whenever endocrine syndromes are …

… The basic study of the biological features of neuroendocrine tumors should allow the
oncologist to identify those tumor subsets more sensitive to a particular medical treatment. For …

… By combining such aggressive surgery with medical treatment, including interferon and
somatostatin analogues, we have achieved a median survival of almost 5 years (56 months) for …